• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 CD28 和 PTEN 为宫颈癌的新型预后标志物。

Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.

机构信息

Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.

Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

J Cell Physiol. 2019 May;234(5):7004-7011. doi: 10.1002/jcp.27453. Epub 2018 Oct 26.

DOI:10.1002/jcp.27453
PMID:30362552
Abstract

Cervical cancer (CC) is the most common malignant tumor with poor clinical outcome among women. Identification of novel biomarkers could be beneficial for the clinical diagnosis and treatment of CC. This study aimed to identify prognostic biomarkers for the prediction of prognostic status of CC patients, and explore the effect of the corresponding methylated genes in the occurrence and development of CC. The methylation microarray data of CC was extracted from The Cancer Genome Atlas (TCGA) dataset. The methylation genes associated with the prognostic status were identified based on the information of the relapse-free survival (RFS) of the CC patients. The prognostic gene pairs were further identified. Then, the prognostic signature was identified by the forward search algorithm based on the C-index method. The results were validated by independent dataset. Finally, the functional analysis was performed on the methylation genes. A total of 276 methylation genes and 2508 gene pairs associated with the prognostic status of the CC were identified. A signature composed of eight methylation gene pairs was obtained to predict the prognostic status of cervical patients. A series of genes that played an important role in the occurrence and development of CC were obtained by the functional enrichment analysis. To summary, a prognostic signature consisting of eight methylation gene pairs was obtained. Of note, the CD28 and PTEN gene pair were found to play important roles in the occurrence and development of CC.

摘要

宫颈癌(CC)是女性中最常见的恶性肿瘤,临床预后较差。鉴定新的生物标志物可能有助于 CC 的临床诊断和治疗。本研究旨在鉴定用于预测 CC 患者预后状态的预后生物标志物,并探讨相应甲基化基因在 CC 发生发展中的作用。从癌症基因组图谱(TCGA)数据集提取 CC 的甲基化微阵列数据。基于 CC 患者无复发生存(RFS)的信息,确定与预后状态相关的甲基化基因。进一步鉴定预后基因对。然后,基于 C 指数法的正向搜索算法确定预后特征。通过独立数据集进行验证。最后,对甲基化基因进行功能分析。鉴定出 276 个与 CC 预后状态相关的甲基化基因和 2508 个基因对。获得了由 8 个甲基化基因对组成的预测宫颈癌患者预后的特征。通过功能富集分析获得了一系列在 CC 发生和发展中起重要作用的基因。总之,获得了一个由 8 个甲基化基因对组成的预后特征。值得注意的是,CD28 和 PTEN 基因对在 CC 的发生和发展中起重要作用。

相似文献

1
Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.鉴定 CD28 和 PTEN 为宫颈癌的新型预后标志物。
J Cell Physiol. 2019 May;234(5):7004-7011. doi: 10.1002/jcp.27453. Epub 2018 Oct 26.
2
A 10-gene prognostic methylation signature for stage I-III cervical cancer.用于 I-III 期宫颈癌的 10 个基因预后甲基化特征。
Arch Gynecol Obstet. 2020 May;301(5):1275-1287. doi: 10.1007/s00404-020-05524-3. Epub 2020 Apr 9.
3
A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.一个 5 基因 DNA 甲基化特征是早期宫颈癌有前途的预后生物标志物。
J Obstet Gynaecol. 2022 Feb;42(2):327-332. doi: 10.1080/01443615.2021.1907563. Epub 2021 Jun 4.
4
Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.分析宫颈癌核编码线粒体基因网络。
Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1799-1811. doi: 10.31557/APJCP.2021.22.6.1799.
5
DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.基于 DNA 甲基化数据的分子亚型分类与宫颈癌患者预后相关。
J Cell Biochem. 2020 Mar;121(3):2713-2724. doi: 10.1002/jcb.29491. Epub 2019 Nov 3.
6
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.由 7 个 miRNA 组成的最优 miRNA 子集可作为宫颈癌进展的新型诊断和预后预测指标。
Oncol Rep. 2019 Jun;41(6):3167-3178. doi: 10.3892/or.2019.7097. Epub 2019 Apr 3.
7
Identification of gene-specific DNA methylation signature for Colorectal Cancer.结直肠癌基因特异性DNA甲基化特征的鉴定
Cancer Genet. 2018 Dec;228-229:5-11. doi: 10.1016/j.cancergen.2018.05.003. Epub 2018 May 26.
8
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.lncRNA SOX21-AS1 的低甲基化在宫颈癌中具有临床预后价值。
Life Sci. 2019 Sep 15;233:116708. doi: 10.1016/j.lfs.2019.116708. Epub 2019 Jul 29.
9
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.鉴定一组组蛋白家族基因特征,用于预测宫颈癌患者的预后。
Sci Rep. 2017 Nov 28;7(1):16495. doi: 10.1038/s41598-017-16472-5.
10
Identifying a Risk Signature of Methylation-Driven Genes as a Predictor of Survival Outcome for Colon Cancer Patients.鉴定甲基化驱动基因的风险特征作为结直肠癌患者生存结局的预测因子。
Appl Biochem Biotechnol. 2024 Jul;196(7):4156-4165. doi: 10.1007/s12010-023-04751-z. Epub 2023 Oct 31.

引用本文的文献

1
Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.基于双链 RNA 结合蛋白相关基因对宫颈癌肿瘤微环境和肿瘤免疫学的特征分析。
J Transl Med. 2023 Sep 21;21(1):647. doi: 10.1186/s12967-023-04505-9.
2
Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer.血清 CXCL8 和 CXCR2 作为宫颈癌无创筛查的诊断生物标志物。
Medicine (Baltimore). 2023 Aug 25;102(34):e34977. doi: 10.1097/MD.0000000000034977.
3
DNA methylation-based predictors of health: applications and statistical considerations.
基于 DNA 甲基化的健康预测指标:应用和统计考虑。
Nat Rev Genet. 2022 Jun;23(6):369-383. doi: 10.1038/s41576-022-00465-w. Epub 2022 Mar 18.
4
Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients.用于预测宫颈癌患者总生存期的六基因特征识别
Onco Targets Ther. 2021 Feb 5;14:809-822. doi: 10.2147/OTT.S276553. eCollection 2021.
5
DNA methylation for cervical cancer screening: a training set in China.用于宫颈癌筛查的 DNA 甲基化:中国的一个训练集。
Clin Epigenetics. 2020 Jun 23;12(1):91. doi: 10.1186/s13148-020-00885-7.
6
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.宫颈癌预后性可变剪接特征的综合分析
Cancer Cell Int. 2020 Jun 8;20:221. doi: 10.1186/s12935-020-01299-4. eCollection 2020.
7
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.基于弹性网络的多基因组合预测宫颈癌患者生存的鉴定。
Med Sci Monit. 2019 Dec 29;25:10105-10113. doi: 10.12659/MSM.918393.
8
Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers.整合 DNA 甲基化和基因表达分析鉴定宫颈癌特异性诊断生物标志物。
Signal Transduct Target Ther. 2019 Dec 13;4:55. doi: 10.1038/s41392-019-0081-6. eCollection 2019.
9
miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.miR-425-5p 与乳腺癌患者的不良预后相关,并通过靶向 PTEN 促进癌细胞进展。
Oncol Rep. 2019 Dec;42(6):2550-2560. doi: 10.3892/or.2019.7371. Epub 2019 Oct 14.
10
Modulation of Type-I Interferon Response by hsa-miR-374b-5p During Japanese Encephalitis Virus Infection in Human Microglial Cells.hsa-miR-374b-5p 在乙型脑炎病毒感染人小神经胶质细胞过程中对 I 型干扰素反应的调控作用。
Front Cell Infect Microbiol. 2019 Aug 9;9:291. doi: 10.3389/fcimb.2019.00291. eCollection 2019.